Auxly Cannabis reports 18% revenue growth and 24% EBITDA rise in Q2 2026, plans expansion and innovation.

Auxly Cannabis Group posted an 18% increase in net revenue to $45.8 million and a 24% rise in adjusted EBITDA to $14.3 million for Q2 2026, driven by higher sales volumes and improved pricing. The company also improved its gross margin to 55% and generated strong cash flow, enabling ongoing investments in product innovation and facility expansion. Auxly completed a 14:1 share consolidation to strengthen its capital structure and plans to invest $10-12 million in 2026 to boost production capacity by 30% by 2028. The company remains focused on sustainable growth in the Canadian market and exploring international opportunities.